Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
Cash flows from operating activities:              
Net loss $ (1,681,000) $ (2,139,000) $ (5,077,000) $ (4,130,000) $ (3,820,000) $ (9,207,000)  
Adjustments to reconcile net loss to net cash used in operating activities              
Depreciation         371,000 259,000  
Stock-based compensation 209,000   249,000   304,000 449,000  
Amortization of debt issuance costs         368,000  
Noncash lease expense         236,000 214,000  
Allowance for inventory reserve         135,000 169,000  
Changes in operating assets and liabilities:              
Accounts receivable         (1,858,000) 913,000  
Inventories         (3,380,000) (9,239,000)  
Other current assets         (17,000) (409,000)  
Accounts payable         6,152,000 2,064,000  
Accrued expenses         89,000 (350,000)  
Accrued interest         1,000  
Office lease payable         (244,000) (211,000)  
Deferred revenue         (82,000) 116,000  
Customer deposits         (146,000) (171,000)  
Net cash used in operating activities         (1,892,000) (15,401,000) $ (23,900,000)
Cash flows from investing activities              
Purchases of equipment         (344,000) (530,000)  
Proceeds from sale of fixed assets         8,000  
Net cash used in investing activities         (336,000) (530,000)  
Cash flows from financing activities:              
Proceeds from issuance of common stock in registered direct offering, net of offering costs         13,971,000  
Proceeds from issuance of common stock in public offering, net of offering costs         1,602,000  
Proceeds from revolving line of credit         30,550,000 3,500,000  
Payment of revolving line of credit         (28,628,000)  
Payment of financed leases         (22,000)  
Net cash provided by financing activities         1,900,000 19,073,000  
Net change in cash         (328,000) 3,142,000  
Cash, beginning of period   $ 485,000   $ 4,713,000 485,000 4,713,000 4,713,000
Cash, end of period $ 157,000   $ 7,855,000   157,000 7,855,000 $ 485,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:              
Initial right of use asset recognition         258,000  
Common stock issued for vested RSUs         114,000  
Supplemental cash flow information:              
Interest paid         $ 288,000 $ 33,000